Clinical Trials as a critical link in rare diseases treatment, will be the focal point of discussion at the Clinical Trials Forum organised by HACRO – Hellenic Association of CROs, which will be attended by Managing Partner Ioanna Michalopoulou on June 8th 2023.
In her speech, she will refer to the EU pharma reform and how it is expected to affect clinical trials, while she will present exclusive comparative data on the legal framework, as applicable in the most advanced countries of the EU with regards to clinical trials, drawing experience and data from our firm’s cooperation with specialist legal firms in Belgium, UK, Netherlands, Spain, Italy and Germany.
For more information, visit https://lnkd.in/dzJHKZYc
